California Cancer Associates for Research and Excellence (cCare)

Fresno, California 93720

0 studies enrolling now · 6 studies all time

What they study most

Breast Adenocarcinoma, Chronic Lymphocytic Leukemia, Hormone Receptor Positive, Non-small Cell Lung Cancer, Pancreatic Cancer, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7, Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIA Lung Non-Small Cell Carcinoma AJCC v7, Stage IIB Breast Cancer AJCC v6 and v7, Stage IIB Lung Non-Small Cell Carcinoma AJCC v7

Studies at this site

• Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) — Running, not enrolling
• Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery — Completed
• Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer — Running, not enrolling
• Efficacy and Safety of Idelalisib in Combination With Ofatumumab for Previously Treated Chronic Lymphocytic Leukemia — Stopped early
• A Phase 1b Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) Combined With Docetaxel in Subjects With Recurrent Previously Treated Locally Advanced or Metastatic NSCLC — Stopped early
• A Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma — Completed